Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Lydia Dreosti | Researchclopedia

Back to researchers

Lydia Dreosti

Steve Biko Hospital

44

Works

5,957

Citations

14

h-index

17

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers HER2/EGFR in Cancer Research CAR-T cell therapy research

Affiliations

Universidade Federal de Minas Gerais2020–2020

University of the Witwatersrand1994–1994

Breast Cancer Research Foundation2013–2013

University of Johannesburg1982–1982

Johannesburg Hospital1982–1982

Top Works

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok,Yi‐Long Wu,et al.

20193,277 citations

Lymphoma Diagnosis and Treatment

Gastric Cancer Management and Outcomes

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response

Evandro de Azambuja,Andrew Holmes,et al.

2014454 citations

Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial

Sara A. Hurvitz,Fabrice André,et al.

2015301 citations

Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial

Hatem A. Azim,Dominique Agbor‐Tarh,et al.

201363 citations

Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer

Andrés Redondo,Nicoletta Colombo,et al.

202051 citations

Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer

Stephen Johnston,Mark Basik,et al.

201649 citations

Intravenous calcium chloride as an antidote to verapamil-induced hypotension

Jeffrey Lipman,Ian Jardine,et al.

198238 citations

Survival of patients with Kaposi’s sarcoma in the South African antiretroviral treatment era: A retrospective cohort study

Mazvita Sengayi,Danuta Kielkowski,et al.

201721 citations

Phase II randomized study of the EGFR, HER2, HER3 signaling inhibitor AZD8931 in combination with anastrozole (A) in women with endocrine therapy (ET) naive advanced breast cancer (MINT).

Stephen Johnston,Mark Basik,et al.

201319 citations